Published in Cancer Weekly, June 26th, 2001
"This marker, measured through a simple blood test, indicates at a very early stage which patients may have prostate cancer that has already begun to spread to other areas of the body," said Dr. Kevin Slawin, associate professor of urology and director of the Baylor Prostate Center, Houston, Texas. "It can give us an early warning for who will need more aggressive therapy."
The findings, which describe the association of transforming growth factor beta, or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.